Richard A. Gonzalez, Chairman of the Board and CEO at AbbVie Inc. (ABBV), sold 102,964 shares at $64.73 ($6.7M) on 2015-04-28, disclosed to the SEC on 2015-04-30.
Scheduled sale ($6.7M) by Chairman of the Board and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.72 | 6,994 | $453K | 6.8% |
| 2 | $64.50 | 1,800 | $116K | 1.7% |
| 3 | $64.52 | 800 | $52K | 0.8% |
| 4 | $64.53 | 400 | $26K | 0.4% |
| 5 | $64.56 | 2,100 | $136K | 2.0% |
| 6 | $64.57 | 1,300 |
| $84K |
| 1.3% |
| 7 | $64.58 | 300 | $19K | 0.3% |
| 8 | $64.59 | 800 | $52K | 0.8% |
| 9 | $64.60 | 5,600 | $362K | 5.4% |
| 10 | $64.61 | 3,548 | $229K | 3.4% |
| 11 | $64.62 | 900 | $58K | 0.9% |
| 12 | $64.64 | 3,000 | $194K | 2.9% |
| 13 | $64.65 | 8,100 | $524K | 7.9% |
| 14 | $64.66 | 3,800 | $246K | 3.7% |
| 15 | $64.66 | 200 | $13K | 0.2% |
| 16 | $64.67 | 2,500 | $162K | 2.4% |
| 17 | $64.68 | 4,317 | $279K | 4.2% |
| 18 | $64.69 | 1,805 | $117K | 1.8% |
| 19 | $64.69 | 3,200 | $207K | 3.1% |
| 20 | $64.70 | 400 | $26K | 0.4% |
| 21 | $64.70 | 34,900 | $2.3M | 33.9% |
| 22 | $64.71 | 1,100 | $71K | 1.1% |
| 23 | $64.71 | 8,100 | $524K | 7.9% |
| 24 | $64.72 | 300 | $19K | 0.3% |
| 25 | $64.73 | 1,400 | $91K | 1.4% |
| 26 | $64.73 | 4,000 | $259K | 3.9% |
| 27 | $64.74 | 400 | $26K | 0.4% |
| 28 | $64.74 | 900 | $58K | 0.9% |
| Total | $64.67 avg | 102,964 | $6.7M | 100% |
| Filing → |
| ABBV | SELL | 2024-07-19 | $49.5M | — | Filing → |
| ABBV | SELL | 2024-03-01 | $49.1M | — | Filing → |
| ABBV | SELL | 2023-08-02 | $11.7M | — | Filing → |